Literature DB >> 23888345

Delayed diagnosis of lyme neuroborreliosis presenting with abducens neuropathy without intrathecal synthesis of Borrelia antibodies.

Daiva Radzišauskienė1, Arvydas Ambrozaitis, Eglė Marciuškienė.   

Abstract

Lyme borreliosis is the most common tick-born infection in Europe. Global climate change expanding the range of tick vectors and an increase in the incidence suggest that this disease will remain an important health issue in the forthcoming decades. Lyme borreliosis is a multisystem organ disorder affecting the nervous system in 10% to 15% of cases. Lyme neuroborreliosis can present with any disorder of the central and peripheral nervous systems. The neuro-ophthalmological manifestations are a rare feature of the disease. The intrathecal synthesis of Borrelia burgdorferi antibodies is of diagnostic importance, but in rare cases, immunoglobulins against the Borrelia burgdorferi antigen may not be detected. We report a case of possible Lyme neuroborreliosis presenting with sixth cranial nerve neuropathy at the onset of the disease further developing into typical meningoradiculitis and multiple mononeuropathy. Surprisingly, Borrelia burgdorferi antibodies were not detected in the cerebrospinal fluid.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23888345

Source DB:  PubMed          Journal:  Medicina (Kaunas)        ISSN: 1010-660X            Impact factor:   2.430


  3 in total

Review 1.  Relevance of chronic lyme disease to family medicine as a complex multidimensional chronic disease construct: a systematic review.

Authors:  Liesbeth Borgermans; Geert Goderis; Jan Vandevoorde; Dirk Devroey
Journal:  Int J Family Med       Date:  2014-11-24

2.  Lyme Disease Presenting with Multiple Cranial Nerve Deficits: Report of a Case.

Authors:  Abhishek Chaturvedi; Keith Baker; Donald Jeanmonod; Rebecca Jeanmonod
Journal:  Case Rep Emerg Med       Date:  2016-08-21

3.  Suicide and Lyme and associated diseases.

Authors:  Robert C Bransfield
Journal:  Neuropsychiatr Dis Treat       Date:  2017-06-16       Impact factor: 2.570

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.